2Wiklund I,Bardhan KD,Muller-Lissner S et al.Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine.Results from a multicentre clinical trial.The European Study Group.Ital J Gastroenterol Hepatol,1998,30:19
3Adachi K,Hashimoto T,Hamamoto N et al.Symptom relief in patients with refiux esophagitis:comparative study of omeprazole,lansoprazole,and rabeprazole.J Gastroenterol Hepatol,2003,18:1 392
4Remedios M,Campbell C,Jones DM et al.Eosinophilic esophagitis in adults:clinical,endoscopic,histologic findings,and response to treatment with fluticasone propionate.Gastrointest Endosc,2006,63:3
5Liacouras CA,Spergel JM,Ruchelli E et al.Eosinophilic esophagitis:a 10-year experience in 381 children.Clin Gastroenterol Hepatol,2005,3:1 198
6Miner P Jr,Orr W,Filippone J et al.Rabeprazole in nonerosive gastroesophageal reflix disease:a randomized placebo-controlled trial.Am J Gastroenterol,2002,97:1 332
7Vieth M,Haringsma J,Delarive J et al.Redstreaks in the oesophagus in patients with reflux disease:is there a histomorpholigical correlate? Scand J Gastroenterol,2001,36:1 123
8Winans CS.Manometric asymmeny or the loweresophageal high-pressure zone.Am J Dig Dis,1977,22:348
9Adachi K,Fujishiro H,Katsube T et al.Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis.J Gastroenterol Hepatol,2001,16:1 191
10Sugiura T,Iwakiri K,Kotoyori M et al.Relationship between severity of reflux esophagitis according to the Los Angeles classification and esophageal motility.J Gastroenterol,2001,36:226
二级参考文献11
1Barrett NR. Chronic peptic ulcer of the esophagus and oesophagitis.Br J Surg, 1950,38:175-182.
2Allison PR,Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax, 1953,8:87-101.
3Barrett, NR. The lower esophagus lined by columner epithelium. Surgery, 1957,41:881-894.
7Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol, 2005, 162 (11): 1050-1061.
8Oberg S, Wenner J, Johansson J, et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg, 2005, 242 (1): 49-54.
9Schena M, Shalon D, Heller R, et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A, 1996, 93 (20): 10614-10619.
10Wang XW, Gao H J, Fang DC. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma. J Dig Dis, 2008, 9 (2): 68-71.
